Hikma Pharmaceuticals Share News (HIK)

WINNERS & LOSERS SUMMARY: Vectura And Hikma Hurt By US FDA Ruling

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------easyJet, up 2.3% at on

FTSE 100 lags Europe on miners and energy, Just Eat goes cold

(For a live blog on European stocks, type LIVE/ in an Eikon news window) * FTSE 100 up 0.1 pct * Just Eat hit by DB downgrade * Vectura, Hikma hit by delay to Advair GKN up 12

UPDATE 1-UK Stocks-Factors to watch on March 12

March 12 (Reuters) - Britain's FTSE 100 index is seen opening up 8 points higher at 7,233 on Monday, according to financial bookmakers, with futures up 0.37 percent ahead

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday March 8 G4SFull Year ResultsAvivaFull Year Year Year EnterprisesHalf 9

LONDON MARKET CLOSE: Unilever Bid Helps FTSE 100 End Week Higher

LONDON MARKET CLOSE: Sterling Rebound, Ex-Divs Send UK Stocks Lower

Hikma signs Easyhaler deal with Orion

(ShareCast News) - Hikma Pharmaceuticals has signed an exclusive licensing and distribution agreement with Finland's Orion for its new Easyhaler combination product for the treatment of asthma and chronic obstructive pulmonary disease. Under the terms of the agreement, Hikma has the exclusive rights

FTSE 100 movers: Rio Tinto zips higher as Reckitt Benckiser falls

(ShareCast News) - FTSE 100 is higher on Friday afternoon thanks to a string of mining behemoths led by Rio Tinto congregating atop the risers' list, albeit offset by a motley group of fallers led by consumer goods giant Reckitt Benckiser. London's top tier index closed 0.40% higher to 7,258.75 poin

BROKER RATINGS SUMMARY: Berenberg Upgrades BAT To Buy From Hold

UPDATE 1-Weak pound buoys GSK but drugmaker warns on 2017 generic threat

* 2017 core EPS seen flat-lower if mid-year generic Advair * Current exchange rates would lift 2017 sterling EPS 9 pct * Q4 2016 core EPS 26.1 pence vs consensus forecast 25.0p (Adds CEO comments, shares, background on new CEO) By Ben Hirschler LONDON, Feb 8 (Reuters) -

Sector movers: Cyclicals bounce back, Evraz in the lead

(ShareCast News) - There was a clear split in the market on Wednesday as cyclicals bounced back and the more defensive segments of the market were relegated to the bottom of the pile. Thus, shares in Prudential and Aviva were to be seen pacing gains among life insurers as yields on benchmark 10-year

LONDON MARKET MIDDAY: Soft Pound Supports FTSE 100 But Pearson Falls

WINNERS & LOSERS SUMMARY: Profit Warnings Crush Pearson, Premier Foods

Hikma gets FDA approval for generic narcolepsy treatment

(ShareCast News) - Hikma Pharmaceuticals' US subsidiary Roxane Laboratories has received approval from the US Food and Drug Administration for its sodium oxybate oral solution for the treatment of cataplexy - sudden loss of muscle strength - and excessive daytime sleepiness in patients with narcolep

Britain's FTSE hits record highs, extends historic winning streak

* FTSE 100 touches new record, sets 14th day of gains * Pharmaceuticals rebound after Trump scare * Housebuilders top the index * ITV buoyed by broker optimism (Adds details and updates prices at close) By Kit Rees and Helen Reid LONDON, Jan 13 (Reuters) - Britain'